Michael T. Redman
Chief Executive Officer at ONCOLIX, INC.
Profile
Michael T.
Redman was the founder of Opexa Pharmaceuticals, Inc. (founded in 2001) where he served as the Chief Executive Officer from 2001 to 2005.
He was also the founder of Oncolix, Inc. (founded in 2006) where he held the position of Chief Executive Officer & Director.
Currently, Mr. Redman is a Director at Oncolix, Inc. He has previously held positions as President, Chief Executive Officer, CFO & Director at Advanced Environmental Petroleum Producers, Inc., Chief Executive Officer at Botanix Pharmaceuticals Ltd., Principal at Wyeth LLC, Principal at Aronex Pharmaceuticals, Inc., Principal at Repros Therapeutics, Inc., Chief Operating Officer & Executive Vice President at Genprex, Inc. (from 2019 to 2021), and Principal at Biovail Pharmaceuticals LLC.
Mr. Redman's education includes an undergraduate degree from the University of Missouri and an MBA from the University of Phoenix.
Michael T. Redman active positions
Companies | Position | Start |
---|---|---|
ONCOLIX, INC. | Chief Executive Officer | - |
Former positions of Michael T. Redman
Companies | Position | End |
---|---|---|
GENPREX, INC. | Chief Operating Officer | 2021-10-14 |
Opexa Pharmaceuticals, Inc. | Chief Executive Officer | 2004-12-31 |
Licensing Executives Society | Corporate Officer/Principal | - |
Advanced Environmental Petroleum Producers, Inc.
Advanced Environmental Petroleum Producers, Inc. Miscellaneous Commercial ServicesCommercial Services Advanced Environmental Petroleum Producers, Inc. operates as a consultant to the electric vehicle research and technologies industry. It focuses on three aspects of the consulting business: operations management, international expansion strategy and marketing. It provides business strategies, based upon client preference, which may include: International and domestic corporate development strategies, Strategic and financial partnering, Project Management, Seminars and Special Events, and Marketing. Advanced Environmental Petroleum Producers was founded by Andrew S. Mynheer in June 2013 and is headquartered in Las Vegas, NV. | Chief Executive Officer | - |
Wyeth Corp.
Wyeth Corp. Pharmaceuticals: MajorHealth Technology Wyeth LLC develops, manufactures, and distributes pharmaceuticals and biological substances. The company was founded in 1926 and is headquartered in Madison, NJ. | Corporate Officer/Principal | - |
Training of Michael T. Redman
University of Missouri | Undergraduate Degree |
University of Phoenix | Masters Business Admin |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 2 |
---|---|
GENPREX, INC. | Health Technology |
BOTANIX PHARMACEUTICALS LIMITED | Health Technology |
Private companies | 9 |
---|---|
Wyeth Corp.
Wyeth Corp. Pharmaceuticals: MajorHealth Technology Wyeth LLC develops, manufactures, and distributes pharmaceuticals and biological substances. The company was founded in 1926 and is headquartered in Madison, NJ. | Health Technology |
Aronex Pharmaceuticals, Inc.
Aronex Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Aronex Pharmaceuticals, Inc. develops proprietary medicines to treat cancer and infectious diseases. The company's products include Nyotran, Atragen, Annamycin, and Zintevir. It is headquartered in The Woodlands, TX. | Health Technology |
Repros Therapeutics, Inc.
Repros Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Repros Therapeutics, Inc. is a development stage biopharmaceutical company, which focuses on the development of drugs to treat hormonal and reproductive systems disorders. Its products include Enclomiphene and Proellex. The company was founded on August 20, 1987 and is headquartered in The Woodlands, TX. | Health Technology |
Advanced Environmental Petroleum Producers, Inc.
Advanced Environmental Petroleum Producers, Inc. Miscellaneous Commercial ServicesCommercial Services Advanced Environmental Petroleum Producers, Inc. operates as a consultant to the electric vehicle research and technologies industry. It focuses on three aspects of the consulting business: operations management, international expansion strategy and marketing. It provides business strategies, based upon client preference, which may include: International and domestic corporate development strategies, Strategic and financial partnering, Project Management, Seminars and Special Events, and Marketing. Advanced Environmental Petroleum Producers was founded by Andrew S. Mynheer in June 2013 and is headquartered in Las Vegas, NV. | Commercial Services |
Opexa Pharmaceuticals, Inc. | Health Technology |
Licensing Executives Society | |
Biovail Pharmaceuticals LLC
Biovail Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Biovail Pharmaceuticals, Inc. researches and develops pharmaceutical medicines. The company products include Wellbutrin SR, Retavase, Zyban and Tiazac XC in Canada and Zovirax Ointment and Zovirax Cream in the United States. The company is headquartered in Bridgewater, NJ. | Health Technology |
Oncolix, Inc. /Old/
Oncolix, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Oncolix, Inc. engages in the development and manufacture of biopharmaceutical products for the treatment of breast cancer. It offers Prolanta, a targeted therapeutic protein for the treatment of ovarian and breast cancer. The company was founded in November 2006 and is headquartered in Houston, TX. | Health Technology |
Oncolix, Inc.
Oncolix, Inc. Pharmaceuticals: MajorHealth Technology Oncolix, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of medical therapies for the treatment of various cancers including ovarian, breast, uterine, and prostate. Its brand Prolanta is a drug designed to block the effect of human prolactin in cancers, either as a stand-alone therapy or in combination with other drugs, by blocking the effect of human prolactin. The company was founded on June 2013 and is headquartered in Houston, TX. | Health Technology |
- Stock Market
- Insiders
- Michael T. Redman